Adherence to medication regimens and participation in dual-focus self-help groups

Psychiatric Services

Volumn 53, Issue 3, 2002, Pages 310-316

  Magura, Stephen ^a   Laudet, Alexandre B ^a   Mahmood, Daneyal ^a   Rosenblum, Andrew ^a   Knight, Edward ^a  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEHAVIOR MODIFICATION; BEHAVIOR THERAPY; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG MONITORING; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH CARE; PATIENT COMPLIANCE; SELF HELP; STRESS; SUBSTANCE ABUSE;

ADULT; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; SELF-HELP GROUPS; SUBSTANCE-RELATED DISORDERS;

EID: 0036190850     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.53.3.310     Document Type: Article

References (44)

1. Compliance with medication regimens for mental and physical disorders
2. Medication compliance among patients with bipolar disorder and substance use disorder
3. Predicting medication noncompliance after hospital discharge among patients with schizophrenia
4. Compliance in psychoses
5. Medication noncompliance and substance abuse among patients with schizophrenia
6. Family characteristics, substance abuse, and hospitalization patterns of patients with schizophrenia
7. Alcohol use and abuse in schizophrenia
8. Sixmonth outcome following a relapse of schizophrenia
9. Substance use among the mentally ill: Prevalence, reasons for use, and effects on illness
10. Substance use disorder and the early course of illness in schizophrenia and affective psychosis
11. Treatment of persons with severe mental illness and substance use disorders in addiction programs
12. Substance abuse and B-cluster disorders: I. Understanding the dual diagnosis patient
13. Psychotropic medication management in persons with co-occurring psychiatric and substance abuse disorders
14. Considerations in using psychotropic medication with dual diagnosis patients in recovery
15. Drug use problem awareness and treatment readiness in dual-diagnosis patients
16. Evaluating an alcohol and drug program for the homeless: An econometric approach
17. A comparative evaluation of substance abuse treatment: V, Substance abuse treatment can enhance the effectiveness of selfhelp groups
18. Outcomes of the treatment climate in psychiatric and substance abuse program
19. Zealous self-help groups as adjuncts to psychiatric treatment: A study of Recovery, Inc.
20. The role of self-help in the recovery process
21. Use of lithium and other medications by members of a self-help group
22. Support, mutual aid, and recovery from dual diagnosis
23. Client ontcomes: II. Longitudinal client data from the Colorado treatment outcome study
24. The development of the Mental Health Confidence Scale: A measure of self-efficacy in individuals diagnosed with mental disorders
25. Initial motivations for alcohol treatment: Relations with patient characteristics, treatment involvement, and dropout
26. Effectiveness of intensive services for crack-dependent women with newborns and young children
27. The fifth edition of the Addiction Severity Index
28. Regression modeling strategies for improved prognostic prediction
29. Practice guidelines for the treatment of patients with substance abuse disorders: Alcohol, cocaine, opioids
30. Psychiatric patients' attitudes about medication and factors affecting noncompliance
31. A prospective multicenter study of patients' refusal of antipsychotic medication
32. Compliance with antipsychotic drug treatment: Influence of side effects
33. Predicting medication compliance in a psychotic population
34. Noncompliance with anti-psychotic depot medication: Users' views on advantages and disadvantages
35. Explaining attitudes toward medication compliance among a seriously mentally ill population
36. Social learning theory and the health belief model
37. Assertive community treatment and medication compliance in the homeless mentally ill